A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC).
第一作者:
Joo-Leng,Low
第一单位:
Laboratory of Precision Oncology and Cancer Evolution, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), 60 Biopolis Street, Genome #02-01, Singapore 138672, Singapore.
作者:
医学主题词
细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);细胞存活(Cell Survival);抗药性, 肿瘤(Drug Resistance, Neoplasm);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);上皮-间质转化(Epithelial-Mesenchymal Transition);荧光抗体技术(Fluorescent Antibody Technique);人类(Humans);模型, 生物学(Models, Biological);突变(Mutation);小分子化合物库(Small Molecule Libraries)
DOI
10.1016/j.ebiom.2021.103220
PMID
33529999
发布时间
2024-09-23
- 浏览0
EBioMedicine
2021年64卷
103220页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



